INmune Bio INMB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.56 | 24 | -21.53 | -5 | -16.02 | 32 |
| 2025Q3 | 2.07 | 25 | -23.86 | -6 | -18.22 | 33 |
| 2025Q2 | 2.31 | 29 | -83.56 | -24 | -64.80 | 38 |
| 2025Q1 | 7.81 | 30 | -31.53 | -10 | -25.18 | 38 |
| 2024Q4 | 4.67 | 32 | -26.05 | -9 | -19.96 | 40 |
| 2024Q3 | 5.39 | 39 | -32.27 | -12 | -22.98 | 53 |
| 2024Q2 | 8.82 | 36 | -30.22 | -10 | -19.63 | 52 |
| 2024Q1 | 11.75 | 28 | -33.63 | -11 | -21.24 | 47 |
| 2023Q4 | 11.26 | 37 | -20.69 | -8 | -14.05 | 57 |
| 2023Q3 | 6.77 | 44 | -18.11 | -9 | -12.93 | 63 |
| 2023Q2 | 9.08 | 51 | -12.27 | -7 | -9.05 | 70 |
| 2023Q1 | 6.46 | 55 | -11.33 | -7 | -8.39 | 74 |
| 2022Q4 | 6.34 | 60 | -9.42 | -6 | -7.04 | 82 |
| 2022Q3 | 6.20 | 64 | -11.56 | -8 | -9.00 | 84 |
| 2022Q2 | 8.84 | 70 | -9.39 | -7 | -7.51 | 88 |
| 2022Q1 | 8.42 | 76 | -8.86 | -7 | -7.11 | 94 |
| 2021Q4 | 10.20 | 80 | -11.48 | -10 | -9.32 | 100 |
| 2021Q3 | 19.42 | 88 | -14.39 | -9 | -11.23 | 108 |
| 2021Q2 | 17.57 | 43 | -12.46 | -7 | -10.52 | 61 |
| 2021Q1 | 11.88 | 64 | -8.91 | -5 | -8.55 | 66 |